LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 162 filers reported holding LEGEND BIOTECH CORP in Q3 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,680,620 | -85.7% | 39,908 | -85.3% | 0.00% | -88.9% |
| Q2 2023 | $18,745,511 | +67134.0% | 271,556 | -53.0% | 0.01% | -43.8% |
| Q1 2023 | $27,881 | +55.1% | 578,202 | +60.6% | 0.02% | +60.0% |
| Q4 2022 | $17,977 | -99.9% | 360,117 | -49.8% | 0.01% | -44.4% |
| Q3 2022 | $29,282,000 | +118.6% | 717,698 | +194.6% | 0.02% | +125.0% |
| Q2 2022 | $13,398,000 | -40.1% | 243,602 | -60.4% | 0.01% | -33.3% |
| Q1 2022 | $22,383,000 | +215.9% | 615,924 | +305.1% | 0.01% | +200.0% |
| Q4 2021 | $7,086,000 | -7.0% | 152,034 | +0.9% | 0.00% | -20.0% |
| Q3 2021 | $7,620,000 | +221.0% | 150,707 | +160.6% | 0.01% | +400.0% |
| Q2 2021 | $2,374,000 | +128.0% | 57,840 | +61.2% | 0.00% | – |
| Q1 2021 | $1,041,000 | -74.2% | 35,874 | -72.6% | 0.00% | -100.0% |
| Q3 2020 | $4,038,000 | -66.3% | 130,802 | -53.5% | 0.01% | -68.8% |
| Q2 2020 | $11,970,000 | – | 281,246 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 1,629,173 | $66,470,000 | 19.56% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,466,453 | $59,831,000 | 8.69% |
| Paradigm Biocapital Advisors LP | 1,076,591 | $43,925,000 | 5.86% |
| HHLR ADVISORS, LTD. | 5,136,617 | $209,574,000 | 5.51% |
| RA Capital Management | 2,338,610 | $95,415,000 | 2.04% |
| Nicholas Investment Partners, LP | 399,486 | $16,299,000 | 1.51% |
| Parkman Healthcare Partners LLC | 121,227 | $4,946,000 | 1.41% |
| Capital International, Inc./CA/ | 1,244,362 | $50,770,000 | 1.13% |
| AtonRa Partners | 28,150 | $1,149,000 | 1.13% |
| Vivo Capital, LLC | 244,375 | $9,971,000 | 1.10% |